Simona Iacobelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor	BONE MARROW TRANSPLANTATION	2020
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)	BONE MARROW TRANSPLANTATION	2020
Death after hematopoietic stem cell transplantation. Changes over calendar year time, infections and associated factors	BONE MARROW TRANSPLANTATION	2020
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION	2020
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation	BONE MARROW TRANSPLANTATION	2020
Allogeneic transplantation in multiple myeloma. Does it still have a place?	JOURNAL OF CLINICAL MEDICINE	2020
Complement C3 vs C5 inhibition in severe COVID-19. Early clinical findings reveal differential biological efficacy	CLINICAL IMMUNOLOGY	2020
Statistical methods in HSCT and cellular therapies	The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies	2019
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: a study on behalf of the European blood and marrow transplant severe aplastic anemia working party	AMERICAN JOURNAL OF HEMATOLOGY	2019
Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation	BRITISH JOURNAL OF HAEMATOLOGY	2019
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION	2018
Incidence of Second Primary Malignancies after Autologous Transplantion for Multiple Myeloma in the Era of Novel Agents	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION	2018
Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities	BONE MARROW TRANSPLANTATION	2018
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION	2018
Melphalan 140mg/M2 Or 200mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party	HAEMATOLOGICA	2018
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT	HAEMATOLOGICA	2018
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita	BRITISH JOURNAL OF HAEMATOLOGY	2018